HS

HÉLÈNE SICARD

IP Innate Pharma: 4 patents #1 of 16Top 7%
Overall (2024): #52,155 of 561,600Top 10%
4
Patents 2024

Issued Patents 2024

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
12084498 Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma Cecile Bonnafous, RENAUD BUFFET 2024-09-10
11999784 Treatment of peripheral T cell lymphoma Cecile Bonnafous, RENAUD BUFFET, Mathieu Blery 2024-06-04
11970535 Treatment with anti-KIR3DL2 agents Carine Paturel 2024-04-30
11858990 KIR3DL2 binding agents Laurent Gauthier, Simon Kollnberger, Benjamin Rossi, Carine Paturel, STÉPHANIE CORNEN +1 more 2024-01-02